Results

Total Results: 2,207 records

Showing results for "drug".

  1. effectivehealthcare-admin.ahrq.gov/products/medication-therapy-management/research-protocol
    December 01, 2019 - Background and Objectives for the Systematic Review The Medicare Prescription Drug … individual patients that are independent of, but can occur in conjunction with, the provision of a drug … substitution issue; complex regimen that can be simplified with same therapeutic benefit; and potential for drug-drug … : needed drug initiated; unnecessary drug discontinued; change in drug dose, form, or frequency; or generic … Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Public Law 108-173.
  2. effectivehealthcare-admin.ahrq.gov/health-topics/opioid-abuse-and-addiction
    April 01, 2021 - Opioid Abuse and Addiction Description Opioids, sometimes called narcotics, are a type of drug … The illegal drug heroin is also an opioid. … Dependence means feeling withdrawal symptoms when not taking the drug. … MAT can help you stop using the drug, get through withdrawal, and cope with cravings. … NIH: National Institute on Drug Abuse Source https://medlineplus.gov/opioidabuseandaddiction.html
  3. effectivehealthcare-admin.ahrq.gov/products/deprescribing-mhs4/rapid-research
    February 01, 2024 - Few adverse drug withdrawal events resulted from deprescribing interventions. … Making Healthcare Safer IV: Active Infection Surveillance of Clostridioides difficile and Multi-Drug … | Sep 7, 2023 Making Healthcare Safer IV: Prevention of Transmission of Infection With Multi-Drug … Healthcare Safer IV: Opioid Stewardship Rapid Evidence Product | Jan 16, 2024 Reducing Adverse Drug … | Feb 9, 2024 Computerized Clinical Decision Support To Prevent Medication Errors and Adverse Drug
  4. effectivehealthcare-admin.ahrq.gov/products/arthritis-psoriatric/research
    December 01, 2019 - EHC FAQs Home Evidence Reports Drug … Report SHARE: Drug … participants, and relevant good- or fair-quality meta-analyses that compared benefits or harms of 14 drug … Literature was synthesized qualitatively within and between the two main drug classes (oral and biologic … Project Timeline Drug Therapy for Psoriatic Arthritis in Adults: Update of a 2007 Report Aug 17
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug … Harms of pregabalin versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of pregabalin versus amitriptyline Author, Year Quality Pain Population Drug Class Drug Assessment … Harms of pregabalin CR versus IR Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of cannabis versus placebo Author, Year Quality Pain Population Drug Assessment Time (Wk) Time
  6. effectivehealthcare-admin.ahrq.gov/products/alcohol-misuse-drug-therapy/consumer
    January 01, 2021 - Food and Drug Administration (FDA) to treat alcohol dependence*. … https://effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/consumer  
  7. effectivehealthcare-admin.ahrq.gov/products/alcohol-misuse-drug-therapy/policymaker
    January 01, 2021 - Food and Drug Administration for AUD include acamprosate (Campral ® , thrice daily), disulfiram (Antabuse … Food and Drug Administration as treatment for alcohol dependence, alcohol abuse, or AUD. … https://effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/policymaker  
  8. effectivehealthcare-admin.ahrq.gov/products/alcohol-misuse-drug-therapy/research
    January 01, 2021 - Food and Drug Administration Web site, ClinicalTrials.gov, and World Health Organization International … https://effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/research  
  9. effectivehealthcare-admin.ahrq.gov/products/alcohol-misuse-drug-therapy/espanol
    January 01, 2021 - Acamprosato (Campral®) : Este medicamento fue aprobado por la Food and Drug Administration (FDA, por … https://effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/espanol  
  10. effectivehealthcare-admin.ahrq.gov/products/alcohol-misuse-drug-therapy/clinician
    January 01, 2021 - Results From the 2013 National Survey on Drug Use and Health: Summary of National Findings. … https://effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/clinician  
  11. effectivehealthcare-admin.ahrq.gov/products/bipolar-disorder-treatment/final-report-2018
    December 01, 2019 - Depression treatment: Evidence was insufficient for drug treatments for depressive episodes in adults … Assess the effect of drug and nondrug interventions for treating acute symptoms associated with bipolar … All drug study findings with at least low-strength evidence were based almost exclusively on adults with … All other drug comparisons to placebo or active controls for acute mania, depression, and maintenance … All antipsychotics approved by the Food and Drug Administration, except aripiprazole, had low-strength
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/off-label-use-research-priorities_research.pdf
    May 01, 2009 - and drug interactions. … Food and Drug Administration, Center for Drug Evaluation and Review. … /Drug Safety Diane Kennedy, RPh, MPH Food and Drug Administration Regulator/Drug Analysis Laurie … has serious side effects.** 2) The drug has frequent side effects. 3) The drug has serious drug-drug … interactions.** 4) The drug has frequent drug-drug interactions.* 5) The drug is approved in other
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug … Harms of pregabalin versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of pregabalin versus amitriptyline Author, Year Quality Pain Population Drug Class Drug Assessment … Harms of pregabalin CR versus IR Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of naproxen versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol.pdf
    September 13, 2024 - Food and Drug Administration (FDA) has commissioned a rapid review on the misuse of attention-deficit … The National Institute on Drug Abuse (NIDA) describes misuse as: “taking a medication in a manner or … Drug Alcohol Depend. 2020 Apr 1;209:107907. doi: 10.1016/j.drugalcdep.2020.107907. … Misuse"[Mesh] OR "Drug Misuse"[Mesh] OR "Prescription Drug Diversion"[Mesh] OR "Substance Abuse, Oral … Misuse"[Mesh] OR "Drug Misuse"[Mesh] OR "Prescription Drug Diversion"[Mesh] OR "Substance Abuse, Oral
  15. S96 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/s96.pdf
    October 01, 2007 - Key Words: adverse drug reaction reporting systems, surveillance, drug safety (Med Care 2007;45: S96 … –S102) An adverse drug event (ADE) occurs when a drug intendedfor therapeutic use has an unintended … or a drug-specific effect. … How the US Food and Drug Administration defines and detects adverse drug events. … Incidence of adverse drug events and potential adverse drug events. Implications for prevention.
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research.pdf
    July 01, 2012 - events) and real (adverse drug events being a subset of the drug related problems) drug related problems … events, and assess medication appropriateness, potential drug-drug and drug-food interactions, dose … drug related problems. … The patient is having an adverse drug event (ADE) as a result of the drug. a. … Does the patient have an allergy to the drug or similar drug? (7.1) b.
  17. S9 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/s9.pdf
    October 01, 2007 - drug subsidy. … Coverage for the prescription drug benefit is provided under various types of prescription drug plans … ) prescription drug plans (MA-PDPs), which offer prescription drug coverage that is integrated with the … Medicare Part D Prescription Drug Event (PDE) Data. … Total Medicare Beneficiaries With Drug Coverage as of June 11, 2006 Description June (Millions) Drug
  18. S13 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/s13.pdf
    October 01, 2007 - , or the drug indication itself. … to prove drug efficacy (ie, the possibility of a beneficial effect in an ideal setting), but not drug … effec- tiveness (ie, whether the drug works in reality).3 Further, information on comparative drug effectiveness … type, how long the drug has been taken, how recently the drug was taken, and demographics of the patient … US Food and Drug Administration.
  19. Data-Points-9 Maps (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-9_maps.pdf
    March 29, 2012 - 2009 Annual Utilization of Sulfonylureas Among Diabetic Beneficiaries With At Least One Antidiabetic Drug … Annual Utilization of Sulfonylureas Among Diabetic Beneficiaries With At Least One Antidiabetic Drug … Annual Utilization of Sulfonylureas Among Diabetic Beneficiaries With At Least One Antidiabetic Drug … Annual Utilization of Sulfonylureas Among Diabetic Beneficiaries With At Least One Antidiabetic Drug … Annual Utilization of Insulin Among Diabetic Beneficiaries With At Least One Antidiabetic Drug
  20. effectivehealthcare-admin.ahrq.gov/products/dietary-supplements/research-protocol
    December 01, 2019 - and Drug-Dietary Supplement Interactions: In the clinical setting, drug-supplement interactions are … more difficult to interpret than drug-drug interactions for a variety of reasons. … Due to U.S. drug regulatory policy, much more research and data are available describing drug-drug interactions … than drug-supplement interactions, and there is a clear need to synthesize information on drug-supplement … . . .cause alterations in cellular drug-transport mechanisms (e.g., drug-transport proteins)?

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: